Financing, Equity Capital Markets

Achilles Therapeutics

03/21
|
$175.0 Million
Piper Sandler served as bookrunner for Achilles Therapeutics, Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma